Permian Investment Partners, LP Bausch Health Companies Inc. Transaction History

Permian Investment Partners, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$7.06 - $23.63 $10.3 Million - $34.5 Million	-1,461,212 Reduced 41.93%	2,024,030 $16.9 Million
Q1 2022 May 13, 2022	SELL	$21.6 - $27.79 $25.2 Million - $32.4 Million	-1,167,000 Reduced 25.08%	3,485,242 $79.6 Million
Q4 2021 Feb 14, 2022	BUY	$23.0 - $29.01 $52.9 Million - $66.7 Million	2,300,000 Added 97.78%	4,652,242 $128 Million
Q3 2021 Nov 15, 2021	SELL	$25.04 - $30.06 $9.72 Million - $11.7 Million	-388,080 Reduced 14.16%	2,352,242 $65.5 Million
Q2 2021 Aug 16, 2021	BUY	$27.43 - $32.7 $2.99 Million - $3.56 Million	108,894 Added 4.14%	2,740,322 $80.3 Million
Q1 2021 May 17, 2021	SELL	$21.37 - $34.38 $65.9 Million - $106 Million	-3,083,527 Reduced 53.96%	2,631,428 $83.5 Million
Q4 2020 Feb 16, 2021	BUY	$15.31 - $21.12 $8.68 Million - $12 Million	566,655 Added 11.01%	5,714,955 $119 Million
Q3 2020 Nov 16, 2020	BUY	$14.88 - $20.13 $11.5 Million - $15.6 Million	775,000 Added 17.72%	5,148,300 $80 Million
Q2 2020 Aug 14, 2020	BUY	$13.31 - $20.51 $58.2 Million - $89.7 Million	4,373,300 New	4,373,300 $80 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Permian Investment Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Permian Investment Partners, LP with notifications on news.